Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
Cancer Res
    August 2026
  1. BACKLUND A, Samaniego CH, Rangaraj R, Campbell C, et al
    Ancestral Genetic Homogeneity in Preclinical Models May Shape Outcome Differences in Pediatric Brain Cancer.
    Cancer Res. 2026;86:3908-3919.
    >> Share

    July 2026
  2. SEN T, Gobbini E, Mustafayev K, Spiegelman LS, et al
    Neurotropism and Therapeutic Targeting of Brain Metastases in Small Cell Lung Cancer.
    Cancer Res. 2026 Jul 9. doi: 10.1158/0008-5472.CAN-25-5968.
    >> Share

  3. LEE E, Kang Y
    MIF-CD74 Signaling Defines a Brain-Specific Immune Vulnerability in Metastasis and Neurologic Disease.
    Cancer Res. 2026;86:3103-3105.
    >> Share

    May 2026
  4. CLUBB JD, Shih RM, Gao TA, Shafer A, et al
    Armored chimeric antigen receptor T-cell therapy targets antigen-heterogeneous glioma.
    Cancer Res. 2026 May 20. doi: 10.1158/0008-5472.CAN-26-1515.
    >> Share

  5. FRIEDEL RH, Zou H
    Interplay of glioblastoma cells with microglia shape invasive phenotypes during long-distance invasion.
    Cancer Res. 2026 May 12. doi: 10.1158/0008-5472.CAN-26-2075.
    >> Share

  6. WANG Y, Sheng X, Yang Y, Liu C, et al
    VGF-Mediated Mitochondrial Remodeling Fuels Lung Adenocarcinoma Brain Metastasis.
    Cancer Res. 2026;86:2104-2125.
    >> Share

    April 2026
  7. FRISKE JD, Cuisin F, Guernalec P, Malone HA, et al
    A Conserved Enhancer Locus in Extrachromosomal DNA and Homogeneously Staining Regions Activates MYC Transcription in Group 3 Medulloblastoma.
    Cancer Res. 2026 Apr 22. doi: 10.1158/0008-5472.CAN-25-4691.
    >> Share

  8. YOUNG RG, Esquea EM, Ciraku L, Merzy J, et al
    ACSS2 Suppresses Ferroptosis to Drive Breast Cancer Brain Metastasis.
    Cancer Res. 2026 Apr 22. doi: 10.1158/0008-5472.CAN-25-3006.
    >> Share

  9. YOUNG JS, Cho NW, Lucas CG, Najem H, et al
    IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.
    Cancer Res. 2026 Apr 13. doi: 10.1158/0008-5472.CAN-25-2922.
    >> Share

    March 2026
  10. WANG C, Sun T, He Y, Yu M, et al
    A Deep Learning-Driven Framework Integrating Organoid-Based Functional Validation Identifies Universal Neoantigens from Recurrent Glioma Mutations.
    Cancer Res. 2026 Mar 26. doi: 10.1158/0008-5472.CAN-25-2679.
    >> Share

  11. ALVARO-ESPINOSA L, Marquez-Galera A, Priego N, Garcia-Calvo V, et al
    MIF-Induced CD74+ Microglia and Macrophages Promote Progression of Brain Metastasis and are Clinically Relevant Across Central Nervous System Disorders.
    Cancer Res. 2026 Mar 24. doi: 10.1158/0008-5472.CAN-25-4018.
    >> Share

  12. VALLEBUONA EJ, Smalley I
    Spatially Resolved Opto-Omics Uncovers Functional Microglial Subtypes in Brain Metastasis.
    Cancer Res. 2026;86:1345-1346.
    >> Share

  13. TSUJI T, Hirose H, Sugiyama D, Shindo M, et al
    Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells.
    Cancer Res. 2026;86:1414-1434.
    >> Share

    February 2026
  14. JUNTTILA MR, Repellin CE, Salaniwal S, Warne R, et al
    Enozertinib Is a Selective, Brain-Penetrant EGFR Inhibitor for Treating Non-Small Cell Lung Cancers with EGFR Exon 20 and Atypical Mutations.
    Cancer Res. 2026;86:759-772.
    >> Share

    January 2026
  15. NAH GSS, Chong YK, Sulaimi FN, Lee KL, et al
    ETC-501 is a Brain Penetrant MNK Kinase Inhibitor that Potentiates TMZ-Induced Senescence and Sensitizes Glioblastoma Cells to Senolytic Therapy.
    Cancer Res. 2026 Jan 22. doi: 10.1158/0008-5472.CAN-24-4388.
    >> Share

  16. KREGER BT, Liang Y, Reilly NM, Spears ME, et al
    CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.
    Cancer Res. 2026;86:438-452.
    >> Share

  17. SCHUFTAN E, Lu IN, de Faria FW, Inserte C, et al
    Integrated Single-Nucleus and Spatial Transcriptomics Elucidate Heterogeneity and Hypoxia-Driven Organization of Supratentorial Ependymoma.
    Cancer Res. 2026;86:540-555.
    >> Share

  18. KRATTLI RP JR, Do AH, El-Khatib SM, Alikhani L, et al
    C5aR1 Inhibition Alleviates Cranial Radiation-Induced Cognitive Decline.
    Cancer Res. 2026;86:255-272.
    >> Share

    December 2025
  19. RIVERA-CARABALLO KA, Lee TJ, Sinha A, Orecchioni M, et al
    Oncolytic HSV-1-Mediated JAG1 Blockade Induces Glioma Senescence-Associated Secretory Phenotype to Increase Macrophage Activation and Cetuximab-Mediated Senolysis.
    Cancer Res. 2025 Dec 18. doi: 10.1158/0008-5472.CAN-25-1402.
    >> Share

  20. XIA Z, Liu W, Guo D, Chen L, et al
    circADAMTS12 Inhibits the Antitumor Activity of Microglia to Enable Metastatic Colonization in the Brain.
    Cancer Res. 2025;85:4977-4994.
    >> Share

    November 2025
  21. GANGWANI K, Lu C, Dhanda SK, Sioson E, et al
    The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients.
    Cancer Res. 2025 Nov 5:OF1-OF9. doi: 10.1158/0008-5472.CAN-24-4976.
    >> Share

    October 2025
  22. KIM KW, Choi HJ, Lee JH
    White matter injury fuels early progression of glioblastoma.
    Cancer Res. 2025 Oct 1. doi: 10.1158/0008-5472.CAN-25-4362.
    >> Share

    September 2025
  23. KHAN F, Petrosyan E, Liu Y, Bahrami A, et al
    Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis.
    Cancer Res. 2025 Sep 18. doi: 10.1158/0008-5472.CAN-25-1791.
    >> Share

  24. CUI Y, Phuong K, Abdelfattah NS, Temple HM, et al
    Quantitative Cell Type Specific Immunopeptidome Analysis of Macrophage and Tumor Co-evolution Reveals Therapeutic MHC-I Peptides in Glioblastoma.
    Cancer Res. 2025 Sep 18. doi: 10.1158/0008-5472.CAN-24-4674.
    >> Share

  25. AHN JY, Dong W, Puri A, Vasquez M, et al
    Spatial Crosstalk Modeling of the Tumor Microenvironment Identifies CCR5-Mediated Glia-to-Glia Signaling as a Key Regulator of Brain Metastatic Progression.
    Cancer Res. 2025 Sep 16. doi: 10.1158/0008-5472.CAN-25-0237.
    >> Share

    August 2025
  26. PAI B, Ramos SI, Cheng WS, Joshi T, et al
    Spatial Multi-omics Defines a Shared Tumor Infiltrative Signature at the Resection Margin in High-Grade Gliomas.
    Cancer Res. 2025 Aug 4. doi: 10.1158/0008-5472.CAN-24-4708.
    >> Share

    July 2025
  27. LIU G, Zhang H, Chen S, Gao J, et al
    Mitochondrial Calcium Uniporter Links Acetyl-CoA Metabolism and H3K27 Acetylation to Maintain Glioblastoma Stem Cells.
    Cancer Res. 2025 Jul 25. doi: 10.1158/0008-5472.CAN-25-0419.
    >> Share

  28. RICHMAN CM, Rasnitsyn A, Holgado BL, Vladoiu M, et al
    Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiation Therapy.
    Cancer Res. 2025 Jul 25. doi: 10.1158/0008-5472.CAN-24-3894.
    >> Share

    June 2025
  29. KHAN KA, Qureshi AA, Xu P, Kuo HY, et al
    Immunological Tolerance to Luciferase and Fluorescent Proteins Using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis.
    Cancer Res. 2025;85:2165-2178.
    >> Share

    May 2025
  30. BALAKRISHNAN I, Madhavan K, Pierce A, Michlin J, et al
    Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma.
    Cancer Res. 2025 May 27. doi: 10.1158/0008-5472.CAN-24-5027.
    >> Share

    April 2025
  31. SANG Y, Li Y, Song L, Alvarez AA, et al
    Editor's Note: TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
    Cancer Res. 2025;85:1342.
    >> Share

    March 2025
  32. KONG Y, Wang F, Jing R, Zhao Q, et al
    Targeting the SP/KLF Transcriptional Regulatory Network Synergizes with HDAC Inhibition to Impede Progression of H3K27M Diffuse Intrinsic Pontine Glioma.
    Cancer Res. 2025 Mar 7. doi: 10.1158/0008-5472.CAN-24-2227.
    >> Share

    February 2025
  33. NOWICKA Z, Rentzeperis F, Tagal V, Teer JK, et al
    Interactions Between Ploidy and Resource Availability Shape Clonal Evolution in Glioblastoma.
    Cancer Res. 2025 Feb 11. doi: 10.1158/0008-5472.CAN-24-0401.
    >> Share

  34. IPPOLITOV D, Lin YH, Spence J, Glogowska A, et al
    The Brain-Penetrant Pan ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases.
    Cancer Res. 2025 Feb 11. doi: 10.1158/0008-5472.CAN-24-1793.
    >> Share

    January 2025
  35. LIU T, Sun T, Chen X, Wu J, et al
    Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Pro-tumorigenic Macrophage Polarization.
    Cancer Res. 2025 Jan 22. doi: 10.1158/0008-5472.CAN-24-2286.
    >> Share

  36. ORR BA
    Transcription Factor Fingerprint Provides Clues for Brain Tumor Cell of Origin.
    Cancer Res. 2025;85:195-196.
    >> Share

  37. JESSA S, De Cola A, Chandarana B, McNicholas M, et al
    FOXR2 Targets LHX6+/DLX+ Neural Lineages to Drive Central Nervous System Neuroblastoma.
    Cancer Res. 2025;85:231-250.
    >> Share

  38. NINOMIYA T, Kemmotsu N, Mukohara F, Magari M, et al
    Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy.
    Cancer Res. 2025 Jan 13. doi: 10.1158/0008-5472.CAN-24-2274.
    >> Share

    December 2024
  39. DRUCKER KL, Jenkins RB, Schramek D
    Switching Drivers: Epigenetic Rewiring to Genetic Progression in Glioma.
    Cancer Res. 2024 Dec 30. doi: 10.1158/0008-5472.CAN-24-4907.
    >> Share

  40. WU CY, Chen Y, Lin YJ, Wei KC, et al
    Tumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression.
    Cancer Res. 2024;84:4017-4030.
    >> Share

    November 2024
  41. ZHOU Z, Yin X, Sun H, Lu J, et al
    PTBP1 Lactylation Promotes Glioma Stem Cell Maintenance through PFKFB4-Driven Glycolysis.
    Cancer Res. 2024 Nov 21. doi: 10.1158/0008-5472.CAN-24-1412.
    >> Share

  42. IZAR B, Kim M
    Peritumoral Venous Vessels: Autobahn and Portal for T cells to Melanoma Brain Metastasis.
    Cancer Res. 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-4054.
    >> Share

  43. CHEN X, Geng Y, Wei G, He D, et al
    Neural Circuitries between the Brain and Peripheral Solid Tumors.
    Cancer Res. 2024;84:3509-3521.
    >> Share

    October 2024
  44. CHEN D, Le SB, Manektalia H, Liu T, et al
    The EP3-ZNF488 Axis Promotes Self-Renewal of Glioma Stem-like Cells to Induce Resistance to Tumor Treating Fields.
    Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-23-3643.
    >> Share

  45. RIMKUS TK, Carpenter RL, Sirkisoon S, Zhu D, et al
    Editor's Note: Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.
    Cancer Res. 2024;84:3310.
    >> Share

    September 2024
  46. PANG L, Zhou F, Chen P
    Lipid-laden macrophages recycle myelin to feed glioblastoma.
    Cancer Res. 2024 Sep 18. doi: 10.1158/0008-5472.CAN-24-3362.
    >> Share

    August 2024
  47. LEE C, Yu D, Kim HS, Kim KS, et al
    Galectin-9 Mediates the Functions of Microglia in the Hypoxic Brain Tumor Microenvironment.
    Cancer Res. 2024 Aug 29. doi: 10.1158/0008-5472.CAN-23-3878.
    >> Share

  48. MACLEOD G, Molaei F, Haider S, Almeida MP, et al
    Fitness Screens Map State-Specific Glioblastoma Stem Cell Vulnerabilities.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-4024.
    >> Share

  49. JIAO M, Pirozzi CJ, Yu C, Bao X, et al
    Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma.
    Cancer Res. 2024 Aug 1. doi: 10.1158/0008-5472.CAN-24-0134.
    >> Share

    July 2024
  50. NAIR NU, Schaffer AA, Gertz EM, Cheng K, et al
    Chromosome 7 gain compensates for chromosome 10 loss in glioma.
    Cancer Res. 2024 Jul 30. doi: 10.1158/0008-5472.CAN-24-1366.
    >> Share

    April 2024
  51. LOW JCM, Cao J, Hesse F, Wright AJ, et al
    Deuterium metabolic imaging differentiates glioblastoma metabolic subtypes and detects early response to chemoradiotherapy.
    Cancer Res. 2024 Apr 18. doi: 10.1158/0008-5472.CAN-23-2552.
    >> Share

    March 2024
  52. HWANG GH, Pazyra-Murphy MF, Seo HS, Dhe-Paganon S, et al
    A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.
    Cancer Res. 2024;84:872-886.
    >> Share

    February 2024
  53. LI J, Shih LK, Brat DJ
    Integrated Proteogenomics Uncover Mechanisms of Glioblastoma Evolution, Pointing to Novel Therapeutic Targets.
    Cancer Res. 2024 Feb 8. doi: 10.1158/0008-5472.CAN-24-0452.
    >> Share

    January 2024
  54. UNDERHILL HR, Karsy M, Davidson CJ, Hellwig S, et al
    Subclonal Cancer Driver Mutations are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas.
    Cancer Res. 2024 Jan 25. doi: 10.1158/0008-5472.CAN-23-2557.
    >> Share

  55. ZHAO D, Verhaak RGW
    Defining the role of extrachromosomal DNA amplifications in medulloblastoma.
    Cancer Res. 2024 Jan 4. doi: 10.1158/0008-5472.CAN-23-4025.
    >> Share

    December 2023
  56. MALTA TM, Sabedot TS, Morosini NS, Datta I, et al
    The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen.
    Cancer Res. 2023 Dec 20. doi: 10.1158/0008-5472.CAN-23-2093.
    >> Share

  57. WANG D, Yan K, Yu H, Li H, et al
    Fimepinostat impairs NF-kappaB and PI3K/AKT signaling and enhances gemcitabine efficacy in H3K27M-mutated diffuse intrinsic pontine glioma.
    Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-0394.
    >> Share

    November 2023
  58. GUO X, Qiu W, Wang C, Qi Y, et al
    Neuronal activity promotes glioma progression by inducing proneural-to-mesenchymal transition in glioma stem cells.
    Cancer Res. 2023 Nov 14. doi: 10.1158/0008-5472.CAN-23-0609.
    >> Share

    September 2023
  59. YIN J, Seo Y, Rhim J, Jin X, et al
    Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells.
    Cancer Res. 2023 Sep 25. doi: 10.1158/0008-5472.CAN-22-3965.
    >> Share

    May 2023
  60. MONDAL I, Das O, Sun R, Gao J, et al
    PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
    Cancer Res. 2023 May 23:CAN-22-3382. doi: 10.1158/0008-5472.CAN-22-3382.
    >> Share

  61. JACKSON ER, Duchatel RJ, Staudt DE, Persson ML, et al
    ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.
    Cancer Res. 2023 May 17:OF1-OF17. doi: 10.1158/0008-5472.CAN-23-0186.
    >> Share

  62. BAYIK D, Bartels CF, Lovrenert K, Watson DC, et al
    Correction: Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets.
    Cancer Res. 2023;83:1757.
    >> Share

  63. JACKSON ER, Duchatel RJ, Staudt DE, Persson ML, et al
    ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.
    Cancer Res. 2023 May 5:CAN-23-0186. doi: 10.1158/0008-5472.CAN-23-0186.
    >> Share

    April 2023
  64. GUETTA-TERRIER C, Karambizi D, Akosman B, Zepecki JP, et al
    Chi3l1 is a modulator of glioma stem cell states and a therapeutic target in glioblastoma.
    Cancer Res. 2023 Apr 27:CAN-21-3629. doi: 10.1158/0008-5472.CAN-21-3629.
    >> Share

  65. MIRZAEI R, D'Mello C, Liu M, Nikolic A, et al
    Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor-Initiating Cells.
    Cancer Res. 2023 Apr 17:OF1-OF17. doi: 10.1158/0008-5472.CAN-22-3004.
    >> Share

  66. KARREMAN MA, Bauer AT, Solecki G, Berghoff AS, et al
    Active Remodeling of Capillary Endothelium via Cancer Cell-Derived MMP9 Promotes Metastatic Brain Colonization.
    Cancer Res. 2023;83:1299-1314.
    >> Share

    March 2023
  67. ZAMLER DB, Hu J
    Primitive Oligodendrocyte Precursor Cells Are Highly Susceptible to Gliomagenic Transformation.
    Cancer Res. 2023;83:807-808.
    >> Share

  68. PINE AR, Cirigliano SM, Singhania R, Nicholson J, et al
    Microenvironment-driven dynamic chromatin changes in glioblastoma recapitulate early neural development at single-cell resolution.
    Cancer Res. 2023 Mar 6:CAN-22-2872. doi: 10.1158/0008-5472.CAN-22-2872.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016